Softbank Vision FUND (aiv M1) L.P. is 10% Owner at Vir Biotechnology, Inc. (VIR). They have made 14 open-market trades across 3 companies since 2019, most recently 2025-11-28.
CIK 0001755143
2 open-market purchases totalling $59.0M since 2019, against 12 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 75% | 100% | 100% |
| Avg Move | -6.4% | -12.1% | -12.1% |
| Scored | 12 | 12 | 12 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VIR | SELL · 10b5-1 | 2025-11-26 | 2025-12-01 | $6.41 | $2.4M | +14.3% | +4.0% | +61.0% |
| VIR | SELL · 10b5-1 | 2025-10-09 | 2025-10-14 | $6.14 | $3.1M | +4.4% | -4.5% | +3.3% |
| VIR | SELL · 10b5-1 | 2023-06-30 | 2023-07-05 | $25.11 | $18K | -4.3% | -43.4% | -61.8% |
| COMP | SELL | 2023-06-07 | 2023-06-09 | $3.69 | $55.4M | -11.8% | -9.3% | -5.3% |
| VIR | SELL | 2023-04-14 | 2023-04-18 | $25.08 | $1.0M | +0.9% | -0.2% | -7.6% |
| VIR | SELL | 2023-02-15 | 2023-02-17 | $26.75 | $1.0M | -21.9% | -17.9% | -14.0% |
| VIR | SELL | 2023-02-03 | 2023-02-07 | $30.21 | $6.9M | -11.4% | -20.8% | -16.9% |
| VIR | SELL | 2023-01-30 | 2023-02-01 | $29.46 | $9.0M | -10.8% | -22.2% | -16.1% |
| VIR | SELL | 2023-01-23 | 2023-01-25 | $28.39 | $1.9M | -4.1% | -26.0% | -19.7% |
| VIR | SELL | 2023-01-19 | 2023-01-23 | $27.13 | $11.6M | +2.2% | -7.7% | -13.2% |
| VIR | SELL | 2022-12-02 | 2022-12-06 | $27.45 | $5.3M | +5.1% | -1.2% | -9.0% |
| VIR | SELL | 2022-11-30 | 2022-12-02 | $27.76 | $11.6M | -6.1% | -9.7% | -18.1% |
| VIR | SELL | 2022-11-23 | 2022-11-28 | $27.27 | $3.1M | -5.3% | -9.0% | -15.3% |
| VIR | SELL | 2022-11-09 | 2022-11-14 | $27.30 | $15.7M | -0.3% | -5.2% | -4.1% |
| VIR | BUY | 2019-10-16 | 2019-10-17 | $20.00 | $19.0M | +3.9% | -9.8% | +7.1% |
| GH | SELL | 2019-09-11 | 2019-09-13 | $77.00 | $377.3M | -13.0% | -16.6% | -5.8% |
| GH | BUY | 2019-03-12 | 2019-03-15 | $9.83 | $40.0M | -25.7% | -24.5% | -8.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.